ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
17.932,17
-1,10%
S&P 500
5.018,39
-0,34%
Dow Jones
37.903,29
0,23%
Euro vs US Dollar
1,07201
0,02%
Bitcoin
57.447,83
-1,36%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. MiMedx Group Inc (MDXG)

  7. MiMedx Group Inc (MDXG) News

MDXG MiMedx Group Inc

7,25
1,09 (17,69%)
02 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
MiMedx Group Inc MDXG NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
1,09 17,69% 7,25 01:44:51
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
6,46 6,33 7,40 7,31 6,16
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
30.4.202422:01GLOBEMIMEDX Announces First Quarter 2024 Operating and Financial..
16.4.202414:00GLOBEMIMEDX to Host First Quarter 2024 Operating and Financial..
27.3.202413:00GLOBEMIMEDX Provides Update on AXIOFILL® Request for Designation..
20.3.202412:00GLOBEMIMEDX Expands Portfolio with Fibrillar Collagen Wound..
13.3.202413:00GLOBEMIMEDX Introduces E-Commerce and Account Management Platform
06.3.202400:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202400:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.3.202400:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.3.202414:11EDGAR2Form 8-K - Current report
04.3.202414:00GLOBEMIMEDX Announces Appointment of Two New Independent..
28.2.202422:22EDGAR2Form 8-K - Current report
28.2.202422:02EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
28.2.202422:01GLOBEMIMEDX Announces Fourth Quarter and Full Year 2023 Operating..
21.2.202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.2.202421:55EDGAR2Form 144 - Report of proposed sale of securities
20.2.202414:00GLOBEMIMEDX to Present at TD Cowen 44th Annual Health Care..
16.2.202422:37EDGAR2Form 144 - Report of proposed sale of securities
16.2.202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.2.202421:11EDGAR2Form 144 - Report of proposed sale of securities
14.2.202422:13EDGAR2Form 144 - Report of proposed sale of securities
12.2.202414:00GLOBEMIMEDX to Host Fourth Quarter and Full Year 2023 Operating..
22.1.202414:09EDGAR2Form 8-K - Current report
22.1.202414:00GLOBEMIMEDX Announces Improved Capital Structure with New Senior..
29.12.202323:00GLOBEMIMEDX Provides AXIOFILL® Update & Reiterates 2023 Full Year..
28.12.202322:30EDGAR2Form 8-K - Current report
28.12.202314:00GLOBEMIMEDX Announces Conversion of Outstanding Series B..
27.12.202322:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.12.202322:42EDGAR2Form SC 13D/A - General statement of acquisition of..
22.11.202323:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.11.202314:14EDGAR2Form 8-K - Current report
13.11.202314:00GLOBEMIMEDX to Participate in Upcoming Investor Conferences
02.11.202313:00GLOBEMIMEDX to Highlight Published Data at SAWC Fall
30.10.202321:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
30.10.202321:05EDGAR2Form 8-K - Current report
30.10.202321:01GLOBEMIMEDX Announces Third Quarter 2023 Operating and Financial..
16.10.202314:00GLOBEMIMEDX to Host Third Quarter 2023 Operating and Financial..
26.9.202314:00GLOBEMIMEDX Announces Launch of EPIEFFECT™
05.9.202323:00EDGAR2Form 8-K - Current report
05.9.202314:38EDGAR2Form 8-K - Current report
05.9.202314:00GLOBEMIMEDX to Present at Upcoming Investor Conferences
01.8.202322:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01.8.202322:03EDGAR2Form 8-K - Current report
01.8.202322:01GLOBEMIMEDX Announces Second Quarter 2023 Operating and Financial..
25.7.202322:22EDGAR2Form S-8 - Securities to be offered to employees in employee..
25.7.202322:19EDGAR2Form S-8 - Securities to be offered to employees in employee..
18.7.202314:00GLOBEMIMEDX to Host Second Quarter 2023 Operating and Financial..
11.7.202314:30GLOBEMIMEDX Announces Favorable Ruling in Putative Securities..
07.7.202300:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.7.202300:12EDGAR2Form 3 - Initial statement of beneficial ownership of..
05.7.202315:02EDGAR2Form 8-K - Current report

Kürzlich von Ihnen besucht

NASDAQ
MDXG
MiMedx
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten